logo

For the Inventor, By the Inventor

Gaithersburg, MD, United States of America

Biosynexus, Inc.


USPTO Granted Patents = 13

% Expired Patents = 100.0



Forward Citations = 84

Loading Chart...
Loading Chart...

18 inventors (with patents filed for the assignee):

goldMedal James J Mond (9 out of 38 patents)

silverMedal Scott Michael Walsh (5 out of 6 patents)

bronzeMedal Andrew Lees (4 out of 30 patents)

4.  Richard F Schuman (4 out of 15 patents)

5.  Simon J Foster (4 out of 13 patents)

6.  Jeffrey R Stinson (4 out of 13 patents)

7.  Gerald Walter Fischer (4 out of 54 patents)

8.  Philip McDowell (3 out of 3 patents)

9.  Simon Clarke (3 out of 3 patents)

10.  Mary Catherine Pittaway (3 out of 3 patents)

11.  Kirsty Brummell (2 out of 2 patents)

12.  Anjali G Shah (2 out of 2 patents)

13.  John Fitzgerald Kokai-Kun (2 out of 2 patents)

14.  Hing C Wong (1 out of 111 patents)

15.  Julie M Adams (1 out of 1 patent)


13 patents:

1. 8697639 - Compositions and methods for treating bacteria (2014-04-15),
2. 8568731 - [object Object] (2013-10-29),
3. 8372958 - Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram posiive bacteria (2013-02-12),
4. 7777017 - Nucleic acids encoding opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria (2010-08-17),
5. 7585658 - Staphylococcus aureus antigenic polypeptides and compositions (2009-09-08),
6. 7576054 - Compositions and methods for treating bacteria (2009-08-18),
7. 7572439 - Enzyme disruption of bacterial biofilms (2009-08-11),
8. 7517852 - Compositions and methods for treating bacteria (2009-04-14),
9. 7452533 - Antimicrobial polymer conjugate containing lysostaphin and polyethylene glycol (2008-11-18),
10. 7410647 - Antigenic polypeptides (2008-08-12),
11. 7250494 - Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria (2007-07-31),
12. 7169903 - Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria (2007-01-30),
13. 7166708 - Process for preparing conjugate vaccines and the conjugate vaccines (2007-01-23),
Company Overview
Biosynexus, Inc. is a biotechnology company based in Gaithersburg, Maryland, specializing in the development of innovative solutions for the healthcare sector. The organization focuses on advanced biomanufacturing processes and the creation of biologics, particularly in the realm of vaccines and therapeutics. By leveraging cutting-edge technology, Biosynexus aims to enhance the efficiency and effectiveness of drug development, contributing to improved patient outcomes and public health initiatives.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

13 Patents

#38 in Gaithersburg, MD

#331 in Maryland

#23,854 in US

#45,081 in the World

Gaithersburg, MD (US)
Gaithersburg, MD, United States of America

Biosynexus, Inc.

Forward Citations = 84

18 inventors:

goldMedal James J Mond (9 out of 38 patents)

silverMedal Scott Michael Walsh (5 out of 6 patents)

bronzeMedal Andrew Lees (4 out of 30 patents)

4.  Richard F Schuman (4 out of 15 patents)

5.  Simon J Foster (4 out of 13 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biosynexus, Inc.. Retrieved from https://idiyas.com/company/biosynexus

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…